Marksans Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 338.66 | 389.05 | 355.59 |
| Operating Expense | 239.08 | 255.58 | 264.28 |
| Net Profit | 69.04 | 91.92 | 60.91 |
| Net Profit Margin | 20.39% | 23.63% | 17.13% |
| Earning Per Share | 1.52 | 2.03 | 1.34 |
| EBIDTA | 99.54 | 131.14 | 90.94 |
| Effective Tax Rate | 21.47% | 22.56% | 22.83% |
Particulars
Jun 2026
Revenue338.66
Operating Expense239.08
Net Profit69.04
Net Profit Margin20.39
Earning Per Share1.52
EBIDTA99.54
Effective Tax Rate21.47
